More than 125 million people worldwide suffer from some form of psoriasis. If you’ve struggled with your skin health this ...
New research highlights the significant health care resource utilization burden of generalized pustular psoriasis (GPP), ...
Vanda Pharmaceuticals and AnaptysBio have announced an exclusive worldwide licence agreement to develop and commercialise the ...
Imsidolimab has successfully completed two global Phase 3 studies in Generalized Pustular Psoriasis Vanda expects to immediately begin preparing BLA and MAA applications for the US and EU Anaptys to ...
Recent studies imply that acute generalized exanthematous pustulosis ... while Th-1-derived dermatoses, such as psoriasis and sarcoidosis, are ameliorated. AGEP, a neutrophile, cell-mediated ...
"Vanda and AnaptysBio link for generalised pustular psoriasis therapy" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results